Johnson & Johnson $4.33 billion acquisition of Abbott Laboratories' eye care business

Overview:

• Johnson & Johnson has acquired the Abbott Laboratories eye care business in a $4.33 billion deal.
• The sale continues a trend of high profile activity for Abbott, following the acquisition of Alere this past February and acquisition of St Jude this past April.
• Abbott had owned the eye care business since purchasing it back in 2009.
• The deal is expected to close by Q1 of 2017.
• Cravath Swaine & Moore (Robert Townsend III, Damien Zoubek) advised Johnson & Johnson.
• Wachtell Lipton Rosen & Katz (David Lam, Victor Goldfelb) advised Abbott.

Kurt Stumpo - Journalist - North America and the Caribbean